We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMS
1251
DELISTED
GMS Inc
GMS
| $2.64M | 0.01% |
+38,147
| New | +$2.36M |
|
1252
Medifast
MED
$136M
| $2.64M | 0.01% |
+28,603
| New | +$2.55M |
|
|
ECHO
1253
EchoStar
ECHO
$26.1B
| $2.63M | 0.01% |
151,808
-115,331
| -43% | -$1.94M |
|
|
MBSC
1254
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $2.63M | 0.01% |
251,511
| – | – |
|
1255
Upbound Group
UPBD
$1.13B
| $2.62M | 0.01% |
84,310
+75,155
| +821% | +$2.2M |
|
|
CBRGW
1256
CALL
DELISTED
Chain Bridge I Warrants
CBRGW
| $2.62M | 0.01% |
249,691
-20,708
| -8% | -$1.26K |
|
|
BSLKW
1257
CALL
DELISTED
Bolt Projects Holdings Warrant
BSLKW
| $2.61M | 0.01% |
249,997
| – | – |
|
|
CPRX
1258
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.61M | 0.01% |
+194,003
| New | +$2.79M |
|
1259
Dover
DOV
$28.3B
| $2.6M | 0.01% |
17,600
-168,698
| -91% | -$24.1M |
|
|
B
1260
Barrick Mining
B
$68.5B
| $2.6M | 0.01% |
+153,321
| New | +$2.79M |
|
|
NXGN
1261
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.58M | 0.01% |
159,299
+127,196
| +396% | +$2.11M |
|
1262
Peloton Interactive
PTON
$2.4B
| $2.58M | 0.01% |
+335,116
| New | +$2.85M |
|
|
PLGO
1263
Pelagos Insurance Capital
PLGO
$2.12B
| $2.57M | 0.01% |
+188,182
| New | +$2.5M |
|
1264
Teleflex
TFX
$5.97B
| $2.55M | 0.01% |
+10,535
| New | +$2.64M |
|
1265
Nokia
NOK
$51.8B
| $2.55M | 0.01% |
612,832
-1,091,672
| -64% | -$4.62M |
|
1266
Capital Group Global Growth Equity ETF
CGGO
$11.9B
| $2.52M | ﹤0.01% |
+103,701
| New | +$2.44M |
|
1267
Keros Therapeutics
KROS
$213M
| $2.52M | ﹤0.01% |
62,650
-53,870
| -46% | -$2.36M |
|
|
NVEE
1268
DELISTED
NV5 Global
NVEE
| $2.51M | ﹤0.01% |
+90,640
| New | +$2.22M |
|
|
SOL
1269
DELISTED
Emeren Group
SOL
| $2.5M | ﹤0.01% |
660,828
+62,838
| +11% | +$244K |
|
1270
TORM
TRMD
$3B
| $2.5M | ﹤0.01% |
103,582
-229,152
| -69% | -$6.38M |
|
1271
Texas Roadhouse
TXRH
$13.8B
| $2.5M | ﹤0.01% |
22,284
-189,808
| -89% | -$20.9M |
|
1272
Autodesk
ADSK
$53.7B
| $2.5M | ﹤0.01% |
12,200
-13,900
| -53% | -$2.78M |
|
1273
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $2.49M | ﹤0.01% |
24,200
+1,200
| +5% | +$124K |
|
1274
iShares MSCI Turkey ETF
TUR
$217M
| $2.49M | ﹤0.01% |
88,092
+9,519
| +12% | +$295K |
|
1275
Masco
MAS
$14.8B
| $2.49M | ﹤0.01% |
+43,313
| New | +$2.27M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.